VBIV logo

VBI Vaccines (VBIV) Shareholders Equity

VBIV Annual Shareholders Equity

$7.53 M
-$56.64 M-88.27%

31 December 2023

VBIV Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBIV Quarterly Shareholders Equity

-$5.47 M
-$12.99 M-172.63%

31 March 2024

VBIV Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBIV Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-88.3%-162.6%
3 y3 years-95.6%-108.5%
5 y5 years-92.3%-108.5%

VBIV Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-95.9%-102.8%

VBI Vaccines Shareholders Equity History

DateAnnualQuarterly
Mar 2024
-
-$5.47 M(-172.6%)
Dec 2023
$7.53 M(-88.3%)
$7.53 M(-62.1%)
Sept 2023
-
$19.89 M(+127.6%)
June 2023
-
$8.74 M(-80.6%)
Mar 2023
-
$45.02 M(-29.8%)
Dec 2022
$64.16 M(-55.4%)
$64.16 M(-23.4%)
Sept 2022
-
$83.82 M(-20.6%)
June 2022
-
$105.56 M(-18.5%)
Mar 2022
-
$129.56 M(-10.0%)
Dec 2021
$143.88 M(-16.2%)
$143.88 M(-10.2%)
Sept 2021
-
$160.14 M(-4.7%)
June 2021
-
$168.08 M(-6.6%)
Mar 2021
-
$180.01 M(+4.8%)
Dec 2020
$171.71 M(+94.6%)
$171.71 M(+3.6%)
Sept 2020
-
$165.81 M(+31.0%)
June 2020
-
$126.61 M(+70.1%)
Mar 2020
-
$74.43 M(-15.7%)
Dec 2019
$88.25 M(-10.1%)
$88.25 M(-9.2%)
Sept 2019
-
$97.22 M(+27.5%)
June 2019
-
$76.25 M(-12.0%)
Mar 2019
-
$86.69 M(-11.7%)
Dec 2018
$98.13 M(-18.1%)
$98.13 M(+27.2%)
Sept 2018
-
$77.13 M(-14.1%)
June 2018
-
$89.80 M(-15.7%)
Mar 2018
-
$106.46 M(-11.1%)
Dec 2017
$119.79 M(+43.1%)
$119.79 M(+90.2%)
Sept 2017
-
$62.97 M(-9.2%)
June 2017
-
$69.36 M(-8.6%)
Mar 2017
-
$75.86 M(-9.4%)
Dec 2016
$83.73 M(+586.7%)
$83.73 M(+5.3%)
Sept 2016
-
$79.50 M(-8.1%)
June 2016
-
$86.53 M(+730.2%)
Mar 2016
-
$10.42 M(-14.5%)
Dec 2015
$12.19 M(-84.9%)
$12.19 M(-58.5%)
Sept 2015
-
$29.42 M(-63.1%)
June 2015
-
$79.66 M(-1.6%)
Mar 2015
-
$80.95 M(-47.3%)
Mar 2015
$80.95 M(-48.4%)
-
Dec 2014
-
$153.58 M(-0.3%)
Sept 2014
-
$154.03 M(-4.8%)
June 2014
-
$161.77 M(+3.1%)
Mar 2014
$156.92 M(-10.5%)
$156.92 M(-4.6%)
Dec 2013
-
$164.51 M(-4.0%)
Sept 2013
-
$171.45 M(+1.4%)
June 2013
-
$169.15 M(-3.6%)
Mar 2013
$175.38 M(-5.0%)
$175.38 M(-2.6%)
Dec 2012
-
$180.00 M(-1.6%)
Sept 2012
-
$182.95 M(+2.1%)
June 2012
-
$179.26 M(-2.9%)
Mar 2012
$184.57 M
$184.57 M(+0.9%)
DateAnnualQuarterly
Dec 2011
-
$182.86 M(+0.3%)
Sept 2011
-
$182.24 M(-7.9%)
June 2011
-
$197.93 M(+25.1%)
Mar 2011
$158.18 M(+3118.6%)
$158.18 M(+834.4%)
Dec 2010
-
$16.93 M(+12.2%)
Sept 2010
-
$15.08 M(+222.6%)
June 2010
-
$4.67 M(-4.9%)
Mar 2010
$4.91 M(+293.5%)
$4.91 M(+6.7%)
Dec 2009
-
$4.60 M(+123.5%)
Sept 2009
-
$2.06 M(+57.4%)
June 2009
-
$1.31 M(+4.8%)
Mar 2009
$1.25 M(-14.5%)
$1.25 M(+6.6%)
Dec 2008
-
$1.17 M(-18.2%)
Sept 2008
-
$1.43 M(-10.3%)
June 2008
-
$1.60 M(+9.3%)
Mar 2008
$1.46 M(+6.3%)
$1.46 M(-10.7%)
Dec 2007
-
$1.63 M(-4.4%)
Sept 2007
-
$1.71 M(-2.1%)
June 2007
-
$1.75 M(+27.2%)
Mar 2007
$1.37 M(+29.1%)
$1.37 M(+15.3%)
Dec 2006
-
$1.19 M(+9.7%)
Sept 2006
-
$1.09 M(-6.5%)
June 2006
-
$1.16 M(+9.2%)
Mar 2006
$1.06 M(+161.9%)
$1.06 M(+168.0%)
Dec 2005
-
$396.90 K(+10.2%)
Sept 2005
-
$360.20 K(-6.5%)
June 2005
-
$385.20 K(-5.2%)
Mar 2005
$406.20 K(+232.7%)
$406.20 K(-17.4%)
Dec 2004
-
$491.90 K(+18.9%)
Sept 2004
-
$413.80 K(-1.2%)
June 2004
-
$418.70 K(+242.9%)
Mar 2004
$122.10 K(-276.2%)
$122.10 K(-16.7%)
Dec 2003
-
$146.60 K(-600.3%)
Sept 2003
-
-$29.30 K(-3355.6%)
June 2003
-
$900.00(-101.3%)
Mar 2003
-$69.30 K(-13.2%)
-$69.30 K(-43.8%)
Dec 2002
-
-$123.20 K(+13.8%)
Sept 2002
-
-$108.30 K(+14.5%)
June 2002
-
-$94.60 K(+18.5%)
Mar 2002
-$79.80 K(-116.3%)
-$79.80 K(-118.0%)
Dec 2001
-
$444.50 K(-3.4%)
Sept 2001
-
$460.30 K(-6.2%)
June 2001
-
$490.70 K(+0.3%)
Mar 2001
$489.30 K(+18.4%)
$489.30 K(-18.4%)
Dec 2000
-
$599.50 K(-3.3%)
Sept 2000
-
$620.00 K(+50.1%)
Mar 2000
$413.10 K(-11.0%)
$413.10 K(-11.0%)
Mar 1999
$463.90 K(-34.2%)
$463.90 K(-34.2%)
Mar 1998
$704.50 K(-35.2%)
$704.50 K(-22.5%)
Dec 1997
-
$908.50 K
Mar 1997
$1.09 M
-

FAQ

  • What is VBI Vaccines annual stockholders equity?
  • What is the all time high annual shareholders equity for VBI Vaccines?
  • What is VBI Vaccines annual shareholders equity year-on-year change?
  • What is VBI Vaccines quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for VBI Vaccines?
  • What is VBI Vaccines quarterly shareholders equity year-on-year change?

What is VBI Vaccines annual stockholders equity?

The current annual shareholders equity of VBIV is $7.53 M

What is the all time high annual shareholders equity for VBI Vaccines?

VBI Vaccines all-time high annual stockholders equity is $184.57 M

What is VBI Vaccines annual shareholders equity year-on-year change?

Over the past year, VBIV annual stockholders equity has changed by -$56.64 M (-88.27%)

What is VBI Vaccines quarterly stockholders equity?

The current quarterly shareholders equity of VBIV is -$5.47 M

What is the all time high quarterly shareholders equity for VBI Vaccines?

VBI Vaccines all-time high quarterly stockholders equity is $197.93 M

What is VBI Vaccines quarterly shareholders equity year-on-year change?

Over the past year, VBIV quarterly stockholders equity has changed by -$14.21 M (-162.57%)